Work

A phase 1 open label trial of intravenous administration of MVA-BN-Brachyury vaccine in patients with advanced cancer.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.2617

Authors: Peter Joseph DeMaria, Katherine Lee-Wisdom, Ravi Amrit Madan, Fatima Karzai, Renee Nicole Donahue, Claudia Palena, Caroline Jochems, Charalampos S. Floudas, Julius Strauss, Jennifer L. Marte, Jason Redman, Houssein Abdul Sater, Borys Korchin, Tatiana Adams, Guenter Silbernagl, Cesar Pico-Navarro, Jeffrey Schlom, James L. Gulley, Marijo Bilusic

Institutions: National Institutes of Health, National Cancer Institute, Bavarian Nordic (United States), Bavarian Nordic (Germany)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3166455571

Cites:

Cited by:

Related to: 10